fbpx
Sponsored Clinical and Research Opportunities2023-09-11T14:57:23-04:00

Sponsored Clinical and Research Opportunities for Patients

Below you will find sponsored clinical trial and research opportunities available to the pulmonary hypertension community.  For a complete list of clinical trials, visit ClinicalTrials.gov. To learn more about research and clinical trials, visit PHAssociation.org/Research.

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals (RARE PAH)

Population: Individuals with HPAH and their family members

Start Date: March 5, 2024

End Date: April 1, 2024

Phase: N/A

Institution: Vanderbilt University Medical Center

Vanderbilt University Medical Center seeks individuals with HPAH and their family members to participate in a study called Risk & Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals (RARE-PAH).

Identification of gene changes, hormonal and blood abnormalities, and how these work together will help in understanding the disease process and may lead to improved therapy.

The study will be conducted over the course of three years with three visits. Participants in this study will receive $100 per visit and up to $300 total for all three visits.

Email Ph_research@vumc.org for more details.

These opportunities are not affiliated with, endorsed by, or supported by the Pulmonary Hypertension Association or its affiliates (collectively, “PHA”).  Participation in these opportunities do not affect your relationship with PHA or its entities. Information obtained by companies or researchers is not shared with PHA or any of its PH-accredited Care Center programs.

Title